DGL · 400 mg Alpha lipoic acid (ALA) et une diminution de l’usage

et une diminution de l’usage d’antibiotiques au sein du groupe ayant reçu des probiotiques comparativement au groupe placebo

PQQ is a novel biofactor known to influence multiple cellular pathways

Médicament homéopathique qui soulage les symptômes de fatulences

Silybum marianum

allows others to breathe and think as they please

DGL · 400 mg Alpha lipoic acid (ALA) et une diminution de l’usageProvides DGL in chewable tablets, the form associated with the greatest clinical efficacy, as it allows licorice to be released in the stomach and dispersed absorbed through the gastric mucosa. Provides 400 mg of DGL per tablet, the clinically effective dose. Deglycyrrhizination prevents adverse effects associated with licorice consumption. Pleasant tasting tablets for improved compliance. Suitable for vegetarians vegans. Deglycyrrhizinated licorice,